Technologies related to NCI

Title
Methods of analyzing virus-derived therapeutics
Ref: E-240-2015 | Updated: Dec 19, 2017
Detection of Colorectal Cancer with Two Novel Heme-Related Molecules in Human Feces
Ref: E-198-2014 | Updated: Jul 19, 2018
Plant-derived Compounds for the Treatment of Retroviral Diseases
Ref: E-201-2012 | Updated: Sep 6, 2017
Peptide Inhibitor for Treating Inflammatory Autoimmune Diseases and Inflammatory Cancers
Ref: E-281-2012 | Updated: Sep 6, 2016
Anti-Mesothelin Monoclonal Antibodies for the Treatment of Cancer
Ref: E-236-2012 | Updated: Jun 7, 2018
Video Monitoring and Analysis System for Vivarium Cage Racks
Ref: E-090-2013 | Updated: Jul 19, 2018
Her2 Monoclonal Antibodies, Antibody Drug Conjugates as Cancer Therapeutics
Ref: E-351-2013 | Updated: Nov 14, 2017
Non-invasive diagnostic and prognostic assay for early stage lung cancer
Ref: E-121-2013 | Updated: Dec 20, 2017
Assay to Screen Anti-metastatic Drugs
Ref: E-088-2013 | Updated: Jun 7, 2018
Co-Transcriptional Assembly of Modified RNA Nanoparticles
Ref: E-223-2012 | Updated: Jun 7, 2018
Nitroxyl (HNO) Releasing Therapeutics
Ref: E-019-2010 | Updated: Mar 29, 2018
Gene Signature for Predicting Solid Tumors Patient Prognosis
Ref: E-024-2009 | Updated: Jul 19, 2018
Allele Specific shRNA for Nanog, and Its Use to Treat Cancer
Ref: E-294-2010 | Updated: May 4, 2018
MUC-1 Tumor Antigen Agonist Epitopes for Enhancing T-cell Responses to Human Tumors
Ref: E-001-2012 | Updated: May 30, 2018
UOK 268 Cell Line for Hereditary Leiomyomatosis and Renal Cell Carcinoma
Ref: E-254-2010 | Updated: Apr 24, 2018
Cancer Vaccine Composed of Oligonucleotides Conjugated to Apoptotic Tumor Cells
Ref: E-266-2009 | Updated: Mar 29, 2018
Silica-Coated Nanodiamonds for Imaging and Delivery of Therapeutic Agents
Ref: E-175-2012 | Updated: Apr 17, 2018
Zirconium-89 PET Imaging Agent for Cancer
Ref: E-111-2013 | Updated: Jul 19, 2018
Peptide Inhibitors for Viral Infections and as Anti-inflammatory Agents
Ref: E-167-2010 | Updated: Aug 31, 2016
HIV-1 Therapeutic Inhibits Viral Entry
Ref: E-033-2013 | Updated: May 30, 2018
Human Antibodies Against Middle East Respiratory Syndrome Coronavirus
Ref: E-002-2014 | Updated: May 30, 2018
Transgenic Mouse Model of Human Basal Triple Negative Breast Cancer
Ref: E-191-2010 | Updated: May 30, 2018
Multifunctional RNA Nanoparticles as Cancer and HIV Therapeutics
Ref: E-765-2013 | Updated: Jun 18, 2018
Nucleic Acid Nanoparticles for Triggering RNA Interference
Ref: E-156-2014 | Updated: Aug 31, 2016
Method and Device for Selectively Labeling RNA
Ref: E-119-2013 | Updated: Apr 18, 2018
Diffuse Large B Cell Lymphoma Therapeutic
Ref: E-035-2013 | Updated: Mar 29, 2018
T-Cell Therapy Against Patient-Specific Cancer Mutations
Ref: E-233-2014 | Updated: Aug 31, 2016
Engineered T Cells that Target Tumor-Specific Mutations
Ref: E-229-2014 | Updated: Aug 31, 2016
Novel Anti-HIV Proteins from Coral Reefs
Ref: E-295-2012 | Updated: Mar 26, 2018
Synthetic lipopeptide inhibitors of RAS oncoproteins
Ref: E-293-2010 | Updated: Aug 31, 2016
Treating JC Polyomavirus Infection and Associated Leukoencephalopathy
Ref: E-549-2013 | Updated: Apr 23, 2018
Individualized Cancer Therapy that Suppresses Tumor Progression & Metastasis
Ref: E-151-2011 | Updated: Sep 6, 2016
GTF2I Mutations as a Genetic Marker for Prognosis of Thymic Malignancies
Ref: E-109-2014 | Updated: Aug 31, 2016
89Zr-Oxine Complex for In Vivo PET Imaging of Labelled Cells and Associated Methods
Ref: E-080-2014 | Updated: Aug 31, 2016
Modulating Chemotherapeutic Cytotoxicity
Ref: E-296-2011 | Updated: Sep 6, 2016
Natural product-based anti-cancer agents: aza-Englerin analogues
Ref: E-090-2014 | Updated: Dec 20, 2017
Novel Anti-HIV Compounds Using Peptides or Peptide Mimetics
Ref: E-019-2014 | Updated: Jul 19, 2018
Novel Immunotherapy for Cancer Treatment: Chimeric Antigen Receptors Targeting CD70 Antigen
Ref: E-021-2015 | Updated: Jul 19, 2018
Ratio Based Biomarkers for the Prediction of Cancer Survival
Ref: E-025-2009 | Updated: Mar 29, 2018
Optical Microscope Software for Breast Cancer Diagnosis
Ref: E-286-2012 | Updated: Sep 30, 2016
Chimeric Antigen Receptors (CARs) for Treating Lymphoma and Other Cancers
Ref: E-001-2016 | Updated: Mar 23, 2018
Engineered Immunotoxins: Improved Targeting for Cancer Therapeutics
Ref: E-197-2015 | Updated: Apr 23, 2018
Processes for Producing and Purifying Nucleic Acid-Containing Compositions
Ref: E-267-2014 | Updated: Dec 17, 2017
Human Monoclonal Antibodies Against Dengue Viruses
Ref: E-273-2011 | Updated: Nov 14, 2017
Use of Anti-CD47 Antibodies for the Treatment of Cancer
Ref: E-263-2014 | Updated: Aug 31, 2016
High-throughput Assay to Identify New Cancer Drugs
Ref: E-031-2013 | Updated: May 30, 2018
Reporter Plasmid to Identify Cancer Stem Cells
Ref: E-141-2011 | Updated: Apr 17, 2018
3D Image Rendering Softwarefor Biological Tissues
Ref: E-254-2012 | Updated: May 30, 2018
Novel Fusion Proteins for HIV Vaccine
Ref: E-256-2012 | Updated: Sep 6, 2016
Method for Generating Pluripotent and Multipotent Cells
Ref: E-086-2012 | Updated: Apr 17, 2018
Improved Production of Prenylated Protein in Insect Cells
Ref: E-009-2015 | Updated: May 30, 2018
Modified griffithsin tandemers for enhanced activity and reduced viral aggregation
Ref: E-034-2013 | Updated: Mar 29, 2018
Improved Pepper Spray for Repellency and Incapacitation
Ref: E-048-2010 | Updated: Dec 19, 2017
B-cell Surface Reactive Antibodies for the Treatment of B-Cell Chronic Lymphocytic Leukemia
Ref: E-163-2009 | Updated: Apr 17, 2018
Vaccines for HIV
Ref: E-087-2015 | Updated: Apr 17, 2018
Metastatic ovarian cancer mouse models and cell lines for preclinical studies
Ref: E-069-2012 | Updated:
Novel Kinase Inhibitors Targeting the PH Domain of AKT for Preventing and Treating Cancer
Ref: E-212-2009 | Updated: Sep 6, 2016
Genomics-based Diagnostic Assay for Cancer
Ref: E-023-2009 | Updated: Jul 19, 2018
Human Monoclonal Antibodies Targeting Glypican-2 in Neuroblastoma
Ref: E-211-2016 | Updated: Jul 19, 2018
Chimeric Antigen Receptors for the treatment of leukemia and other cancers.
Ref: E-133-2016 | Updated: Jul 19, 2018
Biomarker signature development: microRNAs for biodosimetry
Ref: E-066-2015 | Updated: Mar 6, 2017
Therapeutic antibody-drug conjugates targeting CD56-positive cancers
Ref: E-221-2015 | Updated: May 30, 2018
Cancer Immunotherapy Using Virus-like Particles
Ref: E-050-2014 | Updated: Mar 26, 2018
Mouse Model for the Preclinical Study of Metastatic Disease
Ref: E-296-2012 | Updated: Jun 7, 2018
Increased Therapeutic Effectiveness of PE-Based Immunotoxins
Ref: E-263-2011 | Updated: Aug 31, 2016
Treating Hypertension Using Erythropoietin and its Derivatives
Ref: E-158-2012 | Updated: Mar 9, 2018
High-Affinity Mouse Monoclonal Antibodies to GPC-3 for Liver Cancer Research
Ref: E-136-2012 | Updated: Apr 24, 2018
Human T Cell Receptors for Treating Cancer
Ref: E-269-2010 | Updated: May 4, 2018
Tumor Markers for Potentially Predicting Outcome of Anti-angiogenesis Therapy
Ref: E-096-2011 | Updated: Sep 8, 2016
Topical Antibiotic for Faster Wound Healing
Ref: E-294-2011 | Updated: Apr 23, 2018
Nitric Oxide Based Therapeutics for the Treatment of Lung Cancer
Ref: E-025-2010 | Updated: Apr 24, 2018
Improved PE-based Targeted Toxins: A Therapeutic with Increased Effectiveness
Ref: E-269-2009 | Updated: Aug 31, 2016
Immunocompetent Mouse Model for Tracking Cancer Progression
Ref: E-173-2010 | Updated: Jun 18, 2018
Use of Cucurbitacins and Withanolides for the Treatment of Cancer
Ref: E-050-2010 | Updated: Apr 9, 2018
T Cell Receptors that Recognize the Tyrosinase Tumor Antigen
Ref: E-043-2009 | Updated: Jul 19, 2018
Improved Personalized Cancer Immunotherapy
Ref: E-059-2013 | Updated: Mar 9, 2018
Cancer Therapeutic based on Stimulation of Natural Killer T-cell Anti-tumor Activity
Ref: E-034-2010 | Updated: Jul 19, 2018
Treatment of Prostate Cancer using Anti-androgen Small Molecules
Ref: E-015-2011 | Updated: May 30, 2018
High-Affinity Rabbit Monoclonal Antibodies for Cancer Treatment
Ref: E-198-2012 | Updated: Sep 6, 2016
Dual-Function Protein ATIA for Diagnostics and Therapeutics of Glioblastoma
Ref: E-178-2009 | Updated: May 30, 2018
Diabetes, Obesity, and Other Insulin-Related Diseases
Ref: E-042-2012 | Updated: Apr 24, 2018
Cancer Therapeutic Based on T Cell Receptors Designed to Regiospecifically Release Interleukin-12
Ref: E-170-2009 | Updated: Aug 31, 2016
Tempol: A Commercially-Available Nitroxide as a Cancer Therapeutic
Ref: E-133-2009 | Updated: Jul 19, 2018
Virus-Like Particles That Can Deliver Proteins and RNA
Ref: E-264-2011 | Updated: Sep 30, 2016
Cancer Therapies Using Engineered Monomeric Fc Molecules
Ref: E-019-2012 | Updated: Jul 19, 2018
Diagnostic for Cancer of the Adrenal Glands and Adrenal Cortex
Ref: E-135-2012 | Updated: Aug 31, 2016
Detection of Novel Endocrine-Disrupting Chemicals in Water Supplies
Ref: E-269-2011 | Updated: Apr 20, 2016
Diagnostic Marker for Improving Treatment Outcomes of Hepatitis C
Ref: E-217-2011 | Updated: Apr 20, 2018
Phosphodiesterase as a target for cancer therapeutics
Ref: E-199-2010 | Updated: Sep 6, 2016
Lentiviral Vectors with Dual Fluorescence/Luminescence Reporters
Ref: E-132-2011 | Updated: Apr 17, 2018
Polypeptides for Stimulation of Immune Response (Adjuvants)
Ref: E-185-2008 | Updated: Jul 13, 2018
Biomarker for Predicting Taxane Chemotherapy Outcome
Ref: E-191-2009 | Updated: Aug 9, 2017
Agonistic Human Monoclonal Antibodies against Death Receptor 4 (DR4)
Ref: E-158-2010 | Updated: Feb 5, 2018
Software for Accurate Segmentation of Cell Nuclei in Breast Tissue
Ref: E-106-2010 | Updated: Apr 18, 2018
Small-Molecule Inhibitors of Angiogenesis
Ref: E-263-2009 | Updated: May 4, 2018
GATA-3 Reporter Plasmids for Revealing Underlying Mechanisms in Breast Cancer
Ref: E-128-2009 | Updated: Apr 17, 2018
BODIPY-FL Nilotinib (Tasigna) for Use in Cancer Research
Ref: E-009-2010 | Updated: May 30, 2018
New Cancer Research Model: Spontaneously Transformed Mouse Epithelial Cancer Cell Lines
Ref: E-089-2010 | Updated: Mar 9, 2018
Software for Modeling Delivery and Penetration of Antibody Conjugates
Ref: E-060-2012 | Updated: Jun 7, 2018
Modified POTE Peptides for Cancer Immunotherapy
Ref: E-003-2010 | Updated: Jun 19, 2018

Pages

Subscribe to Technologies related to NCI